Tuesday, November 4, 2014
To celebrate Lung Cancer Awareness Month, the Lung Cancer Research Foundation (LCRF) hosted its Ninth Annual Lung Cancer Awareness Luncheon at The Pierre Hotel in New York City. 300 guests joined together to raise more than $700,000 to support LCRF’s mission to fund promising scientific and clinical research on all cancers of the lung.
Presented by Bristol-Myers Squibb, the luncheon served as a forum for the Foundation to announce the recipients of 20 research grants totaling $1 million. Dr. Warren Denning, from MD Anderson Cancer Center, in Houston was the recipient of the 2014 Scientific Merit Award for his project investigating the immune system in small cell lung cancer, an aggressive malignancy accounting for 15% of newly diagnosed lung cancer.
Dr. Charles M. Rudin, Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center, gave the keynote address, offering new hope for patients with lung cancer.
“We often find it difficult to find hope in lung cancer, a disease that kills more people that breast, colon, and prostate cancers combined,” Rudin said. “But there is plenty of hope in the new targeted therapies that are hitting the market, in the paradigm shift in immunotherapy, and with the increased advocacy of early detection and intervention.”
Dr. Rudin praised the Lung Cancer Research Foundation for its commitment to research, especially the Foundation’s open-mindedness in funding innovative new research studies.
The LCRF would like to thank its Presenting Sponsor, Bristol-Myers Squibb, and other key corporate contributors, including Chopard, Dior, Goldman Sachs, Bloomingdale’s and UBS.